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Bone marrow has been considered for long time as the main source for mesenchymal stem
cells. However, bone marrow aspiration is an invasive process that can be associated with
morbidity as well as few numbers of obtained cells. Umbilical cord blood and placental
tissues are other potential sources for the same type of cells. These sources are abundant,
accessible and associated with no harm to the donor. This study aimed at determining the
differentiation of the three cell types towards the osteogenic lineage in short term culture
and in classical osteogenic conditions. The gene expression profile showed that bone
marrow derived cells were the most responsive to the culture conditions while umbilical
cord blood derived cells were next, as shown by the expression by the osteogenic key
transcription factors ‘Runx-2’ and osterix. At the meantime, umbilical cord blood and
placenta derived cells showed significant enhancement of the gene expression over the
study course, which denoted potential response of the cells. Based on these results and the
availability of these two sources, umbilical cord blood and placenta should still be
considered as potential sources for mesenchymal stem cells in osteogenic research pro-
gram. However their differentiation potential will need further enhancement.
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Many patients all over the world are suffering from bone asso-
ciated problems that cannot be satisfactorily treated by the
current management modalities and need physiological
replacement, suchasnon-united fractures, bone cystsandbone
defects, which could be congenital or acquired due to blast in-
juries (Dawson and Oreffo, 2008). The efficient bone regenera-
tion is a hot topic of research based on using different types of
stem cells in order to establish the most efficient protocol for
induction and consequently could be applied in the future for
tissue regeneration programs (Ichinose et al., 2013; Nikukar
et al., 2013). Bone marrow derived stem cells (BM-MSCs) are
considered asmultipotent stem cells that ofmesodermal origin
(mesenchymal stemcells) that are still consideredas the golden
standard for this purpose. These cells can preferentially differ-
entiate into mature cells of their lineage, including the osteo-
blasts (Brooke et al., 2008; Ichinose et al., 2013).
However, the difficulty of obtaining BM-MSCs represents a
significant problem. The current approach is to apply a drill in
the hip bone under anesthesia; a technique which is invasive,
associated with pain and the yield of the cells is variable (Bain,
2001, 2003). Thus looking for other sources of suchmultipotent
cells is anattractive goal of research. These sources include the
umbilical cord blood (UCB) and the placental core derived cells.
UCB contains a cell population that has the characteristics of
mesenchymal stemcells,whichhave similar properties to BM-
MSCs. The differentiation ability of these cells is controversial
in different researchpapers (Jeong et al., 2005; Roobrouck et al.,
2008). At the same time, the abundance and accessibility of
UCB would make it a promising source of stem cells for
research and clinical applications if those cells showed potent
differentiation ability (Ali and Bahbahani, 2010).
Both cell types offer a perfectly natural, controversy-free
source for acquiring stem cells and can be considered as one
of the most abundant sources of non-embryonic stem cells,
bearing in mind that the global birth rate is over 200 million
per year (McGuckin et al., 2006; McGuckin and Forraz, 2008). In
addition, these cells occupy an intermediate stage between
the embryonic stem cells and the adult stem cells, which lead
to higher proliferating potential and longer telomeres than
adult stem cells that are isolated several decades afterwards
(Pipes and Ablin, 2006; Slatter and Gennery, 2006). While there
are many reports regarding UCB cells, placental stem cells
have not received the same attention (Rus et al., 2011).
The differentiation process of the stem cell into the oste-
ogenic lineage had to go acrossmany stages, starting from the
commitment of the cells towards the osteogenic lineage and
ending by the formation of the osteogenicmatrix, inwhich the
cells should be embedded. Such differentiation is associated
with activation of a group of genes. Two transcription factors
are essential for osteoblast differentiation and skeletal
development during the early stages of embryogenesis which
are Runt-related transcription factor-2 (Runx-2) and osterix.
Runx-2 e also is known as Cbfa-1 e is the key transcription
factor during the early stages of embryogenesis (Ducy et al.,
1997, 1999), while osterix is a zinc fingerecontaining tran-
scription factor that is essential for further differentiation and
bone formation. In osterix-null mutant mice, neitherendochondral nor intramembranous bone formation occurs,
and osteoblast differentiation is arrested (Nakashima et al.,
2002). After differentiating to pre-osteoblasts, osterix, and
Runx-2 direct the cells to immature osteoblasts, which pro-
duce bone matrix proteins, during osteoblast differentiation,
Runx-2 up regulates the expression of bone matrix protein
genes including type 1 collagen and alkaline phosphatase
(Jaiswal et al., 2000; Komori, 2010). Collagen1 is the most
abundant protein in animals, makes up about (90e95%) of the
organic content of bone; thus collagen is themain constituent
of the bone matrix. Mutations in type I collagen gene leads to
several forms of bone abnormalities including osteogenesis
imperfecta, EhlerseDanlos syndrome and Marfan syndrome
(Kadler, 1995). Alkaline phosphatase (ALP) is an enzyme that is
produced in bone during the developmental process. ALP
splits pyrophosphate, which is an inhibitor of mineralization,
to provide inorganic phosphate that is required as part of the
mineralization process. ALP activity typically becomes
significantly higher in BM-MSCs cultured in osteogenic con-
ditions compared to cells cultured in basal conditions after 6
days (Mirmalek-Sani et al., 2006).
The aim of the present study is to compare the osteogenic
differentiation potential of cells isolated from the UCB and
placenta with bone marrow derived stem cells. The verifica-
tion of such induction was achieved by determining the level
of gene expression of the osteogenicmaster genes Runx-2 and
osterix, as well as the osteogenic matrix proteins collagen1
and ALP as the markers of osteogenic induction. The impor-
tance of this study was to compare the three sources of stem
cells together, and at themeantime to determine which genes
should be targeted to investigate early differentiation.2. Material and methods
2.1. Sample preparation
The following samples were obtained: a) cancellous bone
segments removed during hip replacement surgery for bone
marrow isolation; b) umbilical cord blood collected after the
delivery and clamping of the cord of full-term babies of
healthy women from the obstetric emergency room; c) pla-
centas, were immediately collected after delivery. All experi-
ments were conducted with passage zero cells. The study was
approved by the research and ethics committees in the Fac-
ulty of Medicine, Suez Canal University.
Femoral drill is a routine step performed during hip
replacement operation, through which a space is created for
inserting the prosthesis, associated with removal of cancel-
lous bony segment. Samples were donated from three pa-
tients and the cells were separated from the bony structure by
repeated vigorous shaking with media (El-Serafi et al., 2011).
The cells were cultured in basal conditions, which are mini-
mum essential medium Eagle's alpha modifications (Sigma-
eAldrich Ltd) with 10% fetal calf serum (Invitrogen) and 100 U/
ml penicillin and 100 U/ml streptomycin (SigmaeAldrich Ltd).
Cord bloodwas dilutedwith phosphate buffered saline and
mononuclear cells were separated using the concentration
gradient centrifugation and cultured in basal conditions. All
placentas were kept in a mixture of phosphate buffered saline
Table 2 e Comparison between the numbers of the cells
obtained from the three sources and the duration needed
till the appearance of spindle-shaped cells.
No. of isolated cells
Mean ± SD in
million cells
Appearance of
spindle-shaped
cells in days
Bone marrow 193 ± 3.37 4.7 ± 1.6*
UCB 142 ± 91.4 6.7 ± 1.6
Placenta 181 ± 9.14 7.1 ± 1.6
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processing within 24 h according to the method described by
Robin and Dzierzak (2010) and Rus et al. (2011). The placentas
were extensively washed to eliminate all blood clumps and
the amniotic and deciduas membranes were completely
removed. Then each placenta was cut into small pieces and
incubated with 1 mg/ml of collagenase IV (SERVA Electro-
phoresis) at 37 C for 1e1.5 h with agitation. Cells were sepa-
rated and cultured in basal conditions.
Stem cells have the property of being adherent to the
plastic surface. Non adherent cells were removed after 24 h.
When the cell density reached 50% of confluency, the media
was changed for the osteogenic induction media. This media
consisted of the basal conditions in addition to 100 mM
ascorbate-2-phosphate (SigmaeAldrich Ltd), and 10 mM
dexamethasone (SigmaeAldrich Ltd) (El-Serafi et al., 2011).3. Molecular biology analysis
RNA was extracted by RNeasy Mini Kit (Qiagen) after the
homoginazition step using the QIA shredder spin column
(Qiagen). RNA was reverse transcribed to cDNA by using
QuantiTect Reverse Transcription Kit (Qiagen). Relative
expression of genes Runx2, osterix, Alp and Collagen type 1
was determined using the real-time polymerase chain reac-
tion (PCR) technique. The expression level of each gene was
determined by a sybergreen based master-mix (Qiagen) and
corrected to the house keeping gene glyceraldehide-3-
phosphate dehydrogenase (GAPDH). The sequences for
different primers are enlisted in Table 1. Data was analyzed
using the Applied Biosystem Software. The quantification was
performed using 2eDDCt method (Livak and Schmittgen, 2001).
The number (n) was 3 per group. Statistical analysis was done
using Statistical Package for Social Science SPSS for WIN-
DOWS software (version 14.0; SPSS Inc, Chicago, IL). Statistical
significance was determined using one-way ANOVA to
compare means between groups, with a p value of less than
0.05 being considered significant.4. Results
The number of cells isolated from each of the three sources
was comparable. After 24 h, the isolated cells were attached to
the tissue culture plastic and acquired the classicalTable 1 e Primer sequences for real time PCR.
Primer Sequence
GAPDH Forward 50CCAGGTGGTCTCCTCTG
Reverse 50TCATACCAGGAAATGAG
Runx2 Forward: 50 TCTTCACAAATCCTCC
Reverse: 50TGGATTAAAAGGACTT
Osterix Forward: 50TAGTGGTTTGGGGTTT
Reverse: 50AACCAACACTCTTATT
ALP Forward: 50AAGGCTTCTTCTTGCT
Reverse: 50GCCTTACCCTCATGATG
Col1 Forward: 50GCCAAGACGAAGACAT
Reverse: 50CCACACGTCTCGGTCAmorphology. The adherent cells acquired the spindle-shape
significantly quicker in BM derived cells, in comparison to
the other sources (Table 2).
The expression of Runx-2 was studied in control (before in-
duction) and 24h after induction. The bonemarrowcontrolwas
set as reference for comparison. Before induction, as shown in
Fig. 1, placental derived cells showed the highest expression of
Runx-2 in comparison to the other sources. BM-MSCs control
expressedsignificantlyhigher levels incomparison toUCBcells.
Upon induction, the expression of Runx-2 was significantly
higher in BM-MSCs in comparison to UCB and placental cells
after 24 h. The extension of the culture into 72 h for UCB and
placenta derived cells failed to significantly enhance the
expression of Runx-2 in comparison to the levels at 24 h.
The expression pattern of the osterix genewas very similar
to that of Runx-2. Osterix was significantly enhanced in bone
marrow derived cells after 24 h. The expression in BM derived
cells was significantly higher than the other cell sources.
Extension of the UCB culture for 72 h significantly enhanced
the expression to match that of the BM at 24 h. Although
osterix expression was enhanced after 24 h of induction of
placental cells, the induction was not significantly enhanced
with the extension of the culture for 72 h. For both time points,
the expression level was significantly lower than bone
marrow (Fig. 2).
The ALP gene was induced only in BM-MSCs. The expres-
sion of ALP was not detected in UCB or placental derived cells
(Fig. 3). Collagen I expression was not detected in all the study
groups.5. Discussion
This study aimed at comparing two possible sources of stem
cells as an alternative for bone marrow for osteogenic tissueReference
ACTTC 30
CTTGACA 30
(Hashimoto et al., 2007)
CC 30
GGTG 30
(Abdallah et al., 2006)
GTTACCGC 30
CCCTAAGT 30
(Tsai et al., 2011)
GGTG 30
TCC 30
(Fujita and Janz, 2007)
CCCA 30
TGG 30
(Yang et al., 2004)
Fig. 1 e Comparison of the expression of Runx-2 between different groups of the study. The BM-MSCs control group was set
as reference. Maximum induction was obtained with BM-MSC after 24 h. Extension of the culture to 72 h didn't show
comparable results. UCB and placenta showed significant enhancement of Runx-2 expression in comparison to their basal
level of expression (n ¼ 3), *p-value is less than 0.05, **p-value is less than 0.05 in comparison to all other groups. ANOVA
test is less than 0.05.
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cord blood was comparable to that reported by previous
studies (Kern et al., 2006; Kawasaki-Oyama et al., 2008) and the
isolation efficacy for placenta was comparable to that re-
ported by Yen et al. (2005); which could indicate relative
steadiness of the separation of the cells from the three re-
ported sources. Such reproducibility may encourage otherFig. 2 e Comparison of the expression of osterix between differe
as reference. Maximum induction was obtained with BM-MSC
culture to 72 h did not show significant enhancement (n¼ 3), *p-
less than 0.05.researchers to use similar protocols for cell separation and
consequently expansion of this research field.
Our gene expression profile showed that BM derived cells
were superior in the expression of the ostoegenic markers in
comparison to the other sources. Such finding was in agree-
ment with Shafiee et al. (2011), and could be explained by the
theory of the stem cell niche. The presence of the BMCs in thent groups of the study. The BM-MSC control group was set
after 24 h as well as UCB-MSC after 72 h. Extension of the
value is less than 0.05, n/s¼ non-significant, ANOVA test is
Fig. 3 e The expression of ALP could only be shown with
BM-MSCs. There was 3.7 folds increase of the ALP
expression after 24 h. Other cell groups failed to show
expression of ALP (n ¼ 3), *p-value is less than 0.05.
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osteogenic environment around these cells. The physical ef-
fects, paracrine secretions, extracellular mediators and the
metabolic products play a role in priming the stem cells to-
wards a certain destination, which is the osteogenic lineage in
case of BM (Lander et al., 2012). At the meantime, this study
reported a trend of gradual increase in Runx-2 and osterix, the
transcription factors responsible for the differentiation of
stem cells into osteocytes, in the other studied cell types. The
expression level of the osteogenic master gene, Runx-2, was
crucial for this purpose. The role of Runx-2 has been proved
in vitro aswell as in some in vivomodels (Bhat et al., 2008). Peng
et al. (2008) reported that Runx-2 expression reached the peak
at 3e7 days in induced BM-MSCs, well ahead of UCB-MSCs.
Wang et al. (2010) seeded the UCB-MSCs on polyglycolic acid
scaffold and showed gradual increase of Runx-2 over three
weeks. The expression level was significantly higher than the
controls on every tested time point including after one week,
which is a consistent finding with our results.
Osterix is another crucial transcription factor that en-
hances bone formation during the normal developmental
process as well as during stem cell differentiation. Our results
showed gradual enhancement of osterix expression in
placental and umbilical cord blood derived cells. The gene
expression profile in UCB-MSCs encapsulated in different
types of carriers showed similar trend over a time-course of
seven days (Zhao et al., 2010). The trends for Runx-2 and
osterix are very similar, which could denote an early stage of
response to induction. In addition, the authors reported the
expression of ALP reached the maximum level after seven
days.
Although our results showed that UCB had better response
to the osteogenic culture conditions than the placenta derived
cells, we should emphasize that the time frame for this study
was concise, because our aim was to investigate the initial
response. The response of the three types of cells on long term
induction time-frame will be interesting to illustrate. Thus,this study highlights the possibility of using UCB and placenta
derived cells for osteogenesis protocols and suggested that the
response of UCB would be superior to placental derived cells.
The addition of other factors that can enhance the process of
osteogenesis, such as 5-Aza-dC (El-Serafi et al., 2011) would be
another interesting field for studying the response in the
different cell sources.r e f e r e n c e s
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